Cite
MLA Citation
P. Gisondi et al.. “Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis.” British journal of dermatology, vol. 183, 2020, pp. 397–398. http://access.bl.uk/ark:/81055/vdc_100105875708.0x000060